Is BEAT Worth Buying in 2026?

Heartbeam, Inc. Common Stock

STOCK SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Updated 2026-04-19

Here’s whether Heartbeam, Inc. Common Stock (BEAT) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Positives: RSI 37 — healthy momentum range. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-7.49% over 10 days); weak 1-year return of -44.6%; 3-month momentum negative (-55.8%). Currently 77.0% off its 52-week high. Score: -5/7.

Ready to act on this? 📈 Trade on Webull

BEAT is trading below its 200-day MA ($1.51) — a key warning sign the longer-term trend is under pressure. An RSI of 36.6 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -44.6% compares to +35.1% for SPY (trailed the market by 79.7%). The current 77.0% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $5,542 today
vs. S&P 500 (SPY) — same period trailed market by 79.7%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($1.51)
Above 50-day MA ($1.29)
RSI(14) neutral zone (30–70) — currently 36.6
Positive return (-44.6%)
!Within 10% of period high (−77.0%)
Period Range $0.92
$0.54 $4.00
RSI (14) 36.6
0 · OversoldOverbought · 100

Key Metrics

Price$0.92
Period Return-44.6%
Period High$4.00
Period Low$0.54
Drawdown−77.0%
MA-50$1.29
MA-200$1.51
RSI (14)36.6
Avg Volume (30d)2.3M
vs. SPYtrailed by 79.7%
Return Rank#907 of 996

Trade BEAT

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers